Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Air Pollution Monitoring for Health Research and Patient Care. An Official American Thoracic Society Workshop Report.

Cromar KR, Duncan BN, Bartonova A, Benedict K, Brauer M, Habre R, Hagler GSW, Haynes JA, Khan S, Kilaru V, Liu Y, Pawson S, Peden DB, Quint JK, Rice MB, Sasser EN, Seto E, Stone SL, Thurston GD, Volckens J.

Ann Am Thorac Soc. 2019 Oct;16(10):1207-1214. doi: 10.1513/AnnalsATS.201906-477ST.

PMID:
31573344
2.

National Asthma and COPD Audit Programme and the NHS Long Term Plan.

Sinha IP, Calvert J, Hickman KC, Hurst JR, McMillan V, Quint JK, Singh SJ, Roberts CM.

Lancet Respir Med. 2019 Oct;7(10):841. doi: 10.1016/S2213-2600(19)30258-9. Epub 2019 Jul 24. No abstract available.

PMID:
31556397
3.

Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017.

Bloom CI, Walker S, Quint JK.

J Asthma. 2019 Oct 9:1-7. doi: 10.1080/02770903.2019.1672723. [Epub ahead of print]

PMID:
31550948
4.

Epidemiology of bronchiectasis in the UK: Findings from the British lung foundation's 'Respiratory health of the nation' project.

Snell N, Gibson J, Jarrold I, Quint JK.

Respir Med. 2019 Sep 17;158:21-23. doi: 10.1016/j.rmed.2019.09.012. [Epub ahead of print]

PMID:
31550642
5.

Characterising low-cost sensors in highly portable platforms to quantify personal exposure in diverse environments.

Chatzidiakou L, Krause A, Popoola OAM, Di Antonio A, Kellaway M, Han Y, Squires FA, Wang T, Zhang H, Wang Q, Fan Y, Chen S, Hu M, Quint JK, Barratt B, Kelly FJ, Zhu T, Jones RL.

Atmos Meas Tech. 2019;12(8):4643-4657. doi: 10.5194/amt-12-1-2019. Epub 2019 Aug 30.

6.

Outcome measures in a combined exercise rehabilitation programme for adults with COPD and chronic heart failure: A preliminary stakeholder consensus event.

Jones AV, Evans RA, Man WD, Bolton CE, Breen S, Doherty PJ, Gardiner N, Houchen-Wolloff L, Hurst JR, Jolly K, Maddocks M, Quint JK, Revitt O, Sherar LB, Taylor RS, Watt A, Wingham J, Yorke J, Singh SJ.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119867952. doi: 10.1177/1479973119867952.

7.

Cost saving of switching to equivalent inhalers and its effect on health outcomes.

Bloom CI, Douglas I, Olney J, D'Ancona G, Smeeth L, Quint JK.

Thorax. 2019 Nov;74(11):1078-1086. doi: 10.1136/thoraxjnl-2018-212957. Epub 2019 Aug 5.

PMID:
31383774
8.

Eligibility for Lung Volume Reduction Surgery in Patients With COPD Identified in a UK Primary Care Setting.

Whittaker HR, Connell O, Campbell J, Elbehairy AF, Hopkinson NS, Quint JK.

Chest. 2019 Aug 2. pii: S0012-3692(19)31391-1. doi: 10.1016/j.chest.2019.07.016. [Epub ahead of print]

PMID:
31381881
9.

Reply to letter to the editor by Dr. Jolobe.

Gulea C, Zakeri R, Quint JK.

Int J Cardiol. 2019 Oct 1;292:161. doi: 10.1016/j.ijcard.2019.06.028. No abstract available.

PMID:
31349938
10.

Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case-control study.

Gayle A, Dickinson S, Poole C, Pang M, Fauconnot O, Quint JK.

NPJ Prim Care Respir Med. 2019 Jul 15;29(1):28. doi: 10.1038/s41533-019-0138-6.

11.

Building toolkits for COPD exacerbations: lessons from the past and present.

Sapey E, Bafadhel M, Bolton CE, Wilkinson T, Hurst JR, Quint JK.

Thorax. 2019 Sep;74(9):898-905. doi: 10.1136/thoraxjnl-2018-213035. Epub 2019 Jul 3.

12.

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting.

Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK.

Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1063-1073. doi: 10.2147/COPD.S200919. eCollection 2019.

13.

Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study.

Gulea C, Zakeri R, Quint JK.

Int J Cardiol. 2019 Sep 1;290:113-118. doi: 10.1016/j.ijcard.2019.04.087. Epub 2019 Apr 30.

PMID:
31101544
14.

Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records.

Pikoula M, Quint JK, Nissen F, Hemingway H, Smeeth L, Denaxas S.

BMC Med Inform Decis Mak. 2019 Apr 18;19(1):86. doi: 10.1186/s12911-019-0805-0.

15.

An observational cohort study of exercise and education for people with chronic obstructive pulmonary disease not meeting criteria for formal pulmonary rehabilitation programmes.

Lewis A, Dullaghan D, Townes H, Green A, Potts J, Quint JK.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119838283. doi: 10.1177/1479973119838283.

16.

COPD and MI: when will we get our act together?

Sundaram V, Quint JK.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 13. pii: qcz016. doi: 10.1093/ehjqcco/qcz016. [Epub ahead of print] No abstract available.

PMID:
30980661
17.

Patterns of breathlessness and associated consulting behaviour: results of an online survey.

Elbehairy AF, Quint JK, Rogers J, Laffan M, Polkey MI, Hopkinson NS.

Thorax. 2019 Aug;74(8):814-817. doi: 10.1136/thoraxjnl-2018-212950. Epub 2019 Apr 8.

18.

Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care.

Bloom CI, Ricciardi F, Smeeth L, Stone P, Quint JK.

BMC Med. 2019 Apr 5;17(1):73. doi: 10.1186/s12916-019-1310-0.

19.

How to validate a diagnosis recorded in electronic health records.

Nissen F, Quint JK, Morales DR, Douglas IJ.

Breathe (Sheff). 2019 Mar;15(1):64-68. doi: 10.1183/20734735.0344-2018.

20.

Code sets for respiratory symptoms in electronic health records research: a systematic review protocol.

Jayatunga W, Stone P, Aldridge RW, Quint JK, George J.

BMJ Open. 2019 Mar 3;9(3):e025965. doi: 10.1136/bmjopen-2018-025965.

21.

Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease.

Lewis A, Axson EL, Potts J, Tarnowska R, Vioix H, Quint JK.

BMJ Open. 2019 Feb 20;9(2):e025048. doi: 10.1136/bmjopen-2018-025048.

22.

Paediatric and adult bronchiectasis: Diagnosis, disease burden and prognosis.

Quint JK, Smith MP.

Respirology. 2019 May;24(5):413-422. doi: 10.1111/resp.13495. Epub 2019 Feb 19. Review.

23.

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016.

Bloom CI, Elkin SL, Quint JK.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 22;14:279-287. doi: 10.2147/COPD.S190086. eCollection 2019.

24.

Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006-2016.

Bloom CI, Saglani S, Feary J, Jarvis D, Quint JK.

Eur Respir J. 2019 Apr 4;53(4). pii: 1802130. doi: 10.1183/13993003.02130-2018. Print 2019 Apr.

PMID:
30765507
25.

Can't see the wood for the trees: confounders, colliders and causal inference - a clinician's approach.

Quint JK, Minelli C.

Thorax. 2019 Apr;74(4):321-322. doi: 10.1136/thoraxjnl-2018-212488. Epub 2019 Feb 7. No abstract available.

26.

Changing causes of death for patients with chronic respiratory disease in England, 2005-2015.

Gayle AV, Axson EL, Bloom CI, Navaratnam V, Quint JK.

Thorax. 2019 May;74(5):483-491. doi: 10.1136/thoraxjnl-2018-212514. Epub 2019 Jan 29.

PMID:
30696745
27.

Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink).

Nissen F, Douglas IJ, Müllerová H, Pearce N, Bloom CI, Smeeth L, Quint JK.

J Asthma Allergy. 2019 Jan 8;12:7-19. doi: 10.2147/JAA.S182013. eCollection 2019.

28.

Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18.

Cook S, Malyutina S, Kudryavtsev AV, Averina M, Bobrova N, Boytsov S, Brage S, Clark TG, Diez Benavente E, Eggen AE, Hopstock LA, Hughes A, Johansen H, Kholmatova K, Kichigina A, Kontsevaya A, Kornev M, Leong D, Magnus P, Mathiesen E, McKee M, Morgan K, Nilssen O, Plakhov I, Quint JK, Rapala A, Ryabikov A, Saburova L, Schirmer H, Shapkina M, Shiekh S, Shkolnikov VM, Stylidis M, Voevoda M, Westgate K, Leon DA.

Version 2. Wellcome Open Res. 2018 Dec 3 [revised 2018 Jan 1];3:67. doi: 10.12688/wellcomeopenres.14619.3. eCollection 2018.

29.

Exacerbation Patterns in Adults with Asthma in England. A Population-based Study.

Bloom CI, Palmer T, Feary J, Quint JK, Cullinan P.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):446-453. doi: 10.1164/rccm.201808-1516OC.

PMID:
30507307
31.

Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK.

Axson EL, Bual N, Bloom CI, Quint JK.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):117-124. doi: 10.1007/s10096-018-3402-8. Epub 2018 Oct 27.

32.

Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care.

Nissen F, Morales DR, Mullerova H, Smeeth L, Douglas IJ, Quint JK.

Br J Gen Pract. 2018 Nov;68(676):e775-e782. doi: 10.3399/bjgp18X699389. Epub 2018 Sep 24.

33.

Mortality after admission for heart failure in the UK compared with Japan.

Nagai T, Sundaram V, Rothnie K, Quint JK, Shoaib A, Shiraishi Y, Kohsaka S, Piper S, McDonagh TA, Hardman SMC, Goda A, Mizuno A, Kohno T, Rigby AS, Yoshikawa T, Clark AL, Anzai T, Cleland JGF.

Open Heart. 2018 Sep 11;5(2):e000811. doi: 10.1136/openhrt-2018-000811. eCollection 2018.

34.

Cottage by the sea or house above the trees: which is better for my lungs?

Amaral AFS, Quint JK.

Thorax. 2018 Dec;73(12):1103-1104. doi: 10.1136/thoraxjnl-2018-212146. Epub 2018 Aug 30. No abstract available.

35.

Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol.

Axson EL, Sundaram V, Bloom CI, Bottle A, Cowie MR, Quint JK.

BMJ Open. 2018 Jun 30;8(6):e023058. doi: 10.1136/bmjopen-2018-023058.

36.

Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016.

Axson EL, Bloom CI, Quint JK.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1795-1803. doi: 10.1007/s10096-018-3315-6. Epub 2018 Jun 27.

37.

Recruitment of patients with Chronic Obstructive Pulmonary Disease (COPD) from the Clinical Practice Research Datalink (CPRD) for research.

Quint JK, Moore E, Lewis A, Hashmi M, Sultana K, Wright M, Smeeth L, Chatzidiakou L, Jones R, Beevers S, Kolozali S, Kelly F, Barratt B.

NPJ Prim Care Respir Med. 2018 Jun 19;28(1):21. doi: 10.1038/s41533-018-0089-3.

38.

Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan.

Nagai T, Sundaram V, Shoaib A, Shiraishi Y, Kohsaka S, Rothnie KJ, Piper S, McDonagh TA, Hardman SMC, Goda A, Mizuno A, Sawano M, Rigby AS, Quint JK, Yoshikawa T, Clark AL, Anzai T, Cleland JGF.

Eur J Heart Fail. 2018 Aug;20(8):1179-1190. doi: 10.1002/ejhf.1210. Epub 2018 May 30.

39.

Response.

Quint JK.

Chest. 2018 May;153(5):1282-1283. doi: 10.1016/j.chest.2018.02.021. No abstract available.

PMID:
29731044
40.

External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.

Morales DR, Flynn R, Zhang J, Trucco E, Quint JK, Zutis K.

Respir Med. 2018 May;138:150-155. doi: 10.1016/j.rmed.2018.04.003. Epub 2018 Apr 12.

41.

Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease.

Rothnie KJ, Connell O, Müllerová H, Smeeth L, Pearce N, Douglas I, Quint JK.

Ann Am Thorac Soc. 2018 Aug;15(8):935-946. doi: 10.1513/AnnalsATS.201710-815OC.

42.

Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results.

Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I.

BMJ Open. 2018 Mar 25;8(3):e019475. doi: 10.1136/bmjopen-2017-019475.

43.

Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.

Rothnie KJ, Müllerová H, Smeeth L, Quint JK.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):464-471. doi: 10.1164/rccm.201710-2029OC.

44.

Low uptake of palliative care for COPD patients within primary care in the UK.

Bloom CI, Slaich B, Morales DR, Smeeth L, Stone P, Quint JK.

Eur Respir J. 2018 Feb 14;51(2). pii: 1701879. doi: 10.1183/13993003.01879-2017. Print 2018 Feb.

45.

Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data.

Morgan AD, Rothnie KJ, Bhaskaran K, Smeeth L, Quint JK.

Thorax. 2018 Sep;73(9):877-879. doi: 10.1136/thoraxjnl-2017-210865. Epub 2018 Feb 3.

46.

COPD exacerbations: transforming outcomes through research.

Hurst JR, Bafadhel M, Bolton CE, Quint JK, Sapey E, Wilkinson TMA.

Lancet Respir Med. 2018 Mar;6(3):172-174. doi: 10.1016/S2213-2600(18)30049-3. Epub 2018 Feb 9. No abstract available.

47.

Defining the relationship between COPD and CVD: what are the implications for clinical practice?

Morgan AD, Zakeri R, Quint JK.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750524. doi: 10.1177/1753465817750524. Review.

48.

Cardiovascular Outcomes after a Respiratory Tract Infection among Adults with Non-Cystic Fibrosis Bronchiectasis: A General Population-based Study.

Navaratnam V, Root AA, Douglas I, Smeeth L, Hubbard RB, Quint JK.

Ann Am Thorac Soc. 2018 Mar;15(3):315-321. doi: 10.1513/AnnalsATS.201706-488OC.

49.

Validation of asthma recording in electronic health records: a systematic review.

Nissen F, Quint JK, Wilkinson S, Mullerova H, Smeeth L, Douglas IJ.

Clin Epidemiol. 2017 Dec 1;9:643-656. doi: 10.2147/CLEP.S143718. eCollection 2017. Review.

50.

Exacerbation risk and characterisation of the UK's asthma population from infants to old age.

Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK.

Thorax. 2018 Apr;73(4):313-320. doi: 10.1136/thoraxjnl-2017-210650. Epub 2017 Oct 26.

Supplemental Content

Loading ...
Support Center